Skip to main content
. 2022 Apr 6;377:e069590. doi: 10.1136/bmj-2021-069590

Fig 2.

Fig 2

Adjusted relative risks with 95% confidence intervals of a first deep vein thrombosis, pulmonary embolism, and bleeding event within 30 days after covid-19 in matched cohort study adjusted for weighted Charlson comorbidity index score, cancer, surgery, and long term anticoagulation treatment. Total cohort consists of individuals who tested positive for SARS-CoV-2 and those who were not reported to the Public Health Agency of Sweden (test negative) as baseline